AzTrials
AzTrials

Postural StabilityTEPStabilNCT03860610

TEPStabil - Muscle Function and Dynamic and Postural Stability in Patients Receiving Hip or Knee Arthroplasty

An observational study of Postural Stability, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Study 1 is to determine if muscle strength and dynamic and postural stability are compromised in patients with severe hip or knee Osteoarthritis (OA) and in patients after THA and TKA. Study 2 is to quantify the effect of THA and TKA on muscle strength and dynamic and postural stability. Read more about this study

Who is it for?
Ages 30 years and olderHealthy volunteers can take part
Conditions the study is for
Postural Stability
What is being tested?
Muscle strength test, Dynamic stability test during level and uphill walking and Postural stability test
How many people
130 participants
Where
1 siteSwitzerland
Study dates
10 Dec 2018to 7 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Participants will be recruited by consecutive recruitment through the contributing surgeons in daily clinical practice, referring physicians and advertisements placed bi-monthly in the University of Basel "Uni-news" and ongoing on the department website. Healthy participants will be recruited by advertisements placed bi-monthly in the University of Basel "Uni-news", local health and sports clubs and ongoing on the department website.

Who may be able to join

  • Patients with an unilateral THA or TKA, which they received for the treatment of osteoarthritis (Patient groups 1+2)
  • Patients diagnosed with unilateral OA of the knee or hip planned for a treatment with THA or TKA (Patient groups 3+4)
  • Age ≥ 30 years (Healthy control group)

Who cannot join

  • Body mass index > 35kg/m2
  • Use of walking aids
  • Neuromuscular disorders affecting gait
  • Inability to follow procedures due to psychological disorders or dementia
  • Diagnosed hip or knee OA (Healthy control group)
  • Current pain in the lower extremities or lower back (Healthy control group)
Show all 9Show fewer
  • Rheumatoid Arthritis (Healthy control group)
  • Previous corrective osteotomy (Healthy control group)
  • Regular intake of pain medication (more than 4 times per week) (Healthy control group)

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Department of Orthopaedics and Traumatology, University Hospital Basel

    Basel, 4031

Other trials in Switzerland

About this study

Study 1 is to determine if muscle strength and dynamic and postural stability are compromised in patients with severe hip or knee Osteoarthritis (OA) and in patients after THA and TKA.

Study 2 is to quantify the effect of THA and TKA on muscle strength and dynamic and postural stability.

Read the detailed description

Postural stability is defined as the ability to maintain the body's centre of gravity within the limits of stability as determined by the base of support. It is further divided in static and dynamic stability involving the ability of maintaining a base of support while standing or completing a functional Task. The importance of postural stability is accepted as a factor predicting falls and affecting the ability to perform activities of daily living.

Despite of reported strength deficits and the importance of balance, to date the potential contribution of strength deficits in patients before and after Total Hip Arthroplasty (THA) or Total Knee Arthroplasty (TKA) to compromised balance ability is unknown. Furthermore, the role of preoperative muscle function on functional outcome of THA and TKA is poorly understood. A correlation between compromised preoperative muscular function and postoperative outcome would suggest that preoperative physical therapy may be critical for preserving the muscular status and may help explain reported poorer outcome after late treatment when muscular function has already deteriorated.

The project includes two studies differing in design and primary and secondary objectives but with overlapping patient populations.

Study 1 will include all five groups, and there is only one visit by the participant (visit A).

Study 2 will include only patients from groups 3 and 4. Three assessments will be performed: preoperatively (visit 1), 6 weeks postoperatively (visit 2) and 1 year postoperative (visit 3). Visit 1 will be identical to visit A in study 1 in these two patient groups.

Being tested
Muscle strength test, Dynamic stability test during level and uphill walking, Postural stability test, EuroQol Group Health questionnaire (EQ-5D-5L), HOOS/ KOOS
Keywords
Total Hip Arthroplasty, Total Knee Arthroplasty, Osteoarthritis, Muscle strength deficits, Dynamic stability
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Muscle strength testDiagnostic test

    Muscle strength in knee flexion and extension and hip abduction will be tested using using a dynamometer (Biodex System 4 Pro: Biodex Medical Systems, Shirley, NY, USA)

  • Dynamic stability test during level and uphill walkingDiagnostic test

    Instrumented gait analysis on an overground walkway with two embedded force plates (Kistler force plate 9260AA6, Kistler AG, Winterthur, Switzerland; sampling rate 2400 Hz) and on a treadmill with an embedded plantar pressure plate (h/p/cosmos, Zebris FDM-T, Isny, Germany)

  • Postural stability testDiagnostic test

    The overall stability index (OSI) will be assessed using the Biodex Balance System SD (Biodex Medical Systems, Inc., Shirley, NY, USA) and is determined by the variance in platform displacement from the horizontal plane.

  • EuroQol Group Health questionnaire (EQ-5D-5L)Diagnostic test

    Overall health will be assessed using the EQ-5D-5L health questionnaire

  • HOOS/ KOOSDiagnostic test

    Site specific pain and function will be assessed with the Hip Osteoarthritis Outcome Score (HOOS) and Knee Injury and Osteoarthritis Outcome Score (KOOS) depending on the affected joint (hip or knee).

  • Muscle activity testDiagnostic test

    Surface electrodes (Ag/AgCl, Noraxon, U.S.A. Inc., Scottsdale, AZ, USA: 10 mm diameter, 22 mm inter-electrode distance) will be placed bilaterally on glutaeus medius, vastus medialis, semitendinosus, tibialis anterior, gastrocnemius medialis, and peroneus longus muscles. Periods of muscle activity will be defined as intensity above 2 Standard Deviation (SD) of the resting Electromyography (EMG) signal. Duration of overlapping muscle activity between agonists and antagonists normalized to one gait cycle or of a balance test, respectively, will be determined.

  • Passive range of motionDiagnostic test

    Passive range of motion will be assessed for ankle plantar-/dorsiflexion, knee flexion/extension and hip flexion/extension, ab/adduction, internal/external rotation using goniometers and recorded in degrees. The range between two maxima will be recorded.

Study groups in NCT03860610
Study groupRoleWhat they receive
Patient group 1 after THAPatients who have already received a THA (N=30) for OA will be assessed 1 year postoperatively (Visit A); Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'
Receives: Diagnostic Test: Muscle strength test; Diagnostic Test: Dynamic stability test during level and uphill walking; Diagnostic Test: Postural stability test; Diagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L); Diagnostic Test: HOOS/ KOOS; Diagnostic Test: Muscle activity test; Diagnostic Test: Passive range of motion
Patient group 2 after TKAPatients who have already received a TKA (N=30) for OA will be assessed 1 year postoperatively (Visit A); Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'
Receives: Diagnostic Test: Muscle strength test; Diagnostic Test: Dynamic stability test during level and uphill walking; Diagnostic Test: Postural stability test; Diagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L); Diagnostic Test: HOOS/ KOOS; Diagnostic Test: Muscle activity test; Diagnostic Test: Passive range of motion
Patient group 3 before THAPatients with severe hip OA (N=30) scheduled to receive a THA will be assessed preoperatively (Visit 1), 12 weeks postoperative (Visit 2) and 1 year postoperative (Visit 3). Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'
Receives: Diagnostic Test: Muscle strength test; Diagnostic Test: Dynamic stability test during level and uphill walking; Diagnostic Test: Postural stability test; Diagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L); Diagnostic Test: HOOS/ KOOS; Diagnostic Test: Muscle activity test; Diagnostic Test: Passive range of motion
Patient group 4 before TKAPatients with severe knee OA (N=30) scheduled to receive a TKA will be assessed preoperatively (Visit 1), 12 weeks postoperative (Visit 2) and 1 year postoperative (Visit 3). Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'
Receives: Diagnostic Test: Muscle strength test; Diagnostic Test: Dynamic stability test during level and uphill walking; Diagnostic Test: Postural stability test; Diagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L); Diagnostic Test: HOOS/ KOOS; Diagnostic Test: Muscle activity test; Diagnostic Test: Passive range of motion
Healthy control groupAge-matched healthy control subjects (N=30);Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'
Receives: Diagnostic Test: Muscle strength test; Diagnostic Test: Dynamic stability test during level and uphill walking; Diagnostic Test: Postural stability test; Diagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L); Diagnostic Test: HOOS/ KOOS; Diagnostic Test: Muscle activity test; Diagnostic Test: Passive range of motion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle strength (Study 1)

    For the knee, maximum isokinetic flexion and extension torques will be collected between full extension and 90° flexion at a movement speed of 60°/s (5 repetitions) and 240°/s (5 repetitions).For the hip, maximum abduction torques will be measured isometrically (5 repetitions) in a standing position. Maximum joint torques in each movement direction will be recorded for each joint and normalized to body weight (study group 1 to 5)

    Measured: single point measurement at Visit A (week 0)

  2. Change in Muscle strength (Study 2)

    For the knee, maximum isokinetic flexion and extension torques will be collected between full extension and 90° flexion at a movement speed of 60°/s (5 repetitions) and 240°/s (5 repetitions).For the hip, maximum abduction torques will be measured isometrically (5 repetitions) in a standing position. Maximum joint torques in each movement direction will be recorded for each joint and normalized to body weight (study group 3 and 4)

    Measured: Three assessments will be performed: preoperatively (visit 1), 6 weeks postoperatively (visit 2) and 1 year postoperative (visit 3).

  3. Postural stability (Study 1)

    The overall stability index (OSI) will be assessed using the Biodex Balance System SD. A high stability index represents the angular excursion of the subject's center of gravity and is indicative of a high degree of movement during a test (i.e.poor balance). (study group 1 to 5)

    Measured: single point measurement at Visit A (week 0)

  4. Change in postural stability (Study 2)

    The overall stability index (OSI) will be assessed using the Biodex Balance System SD. A high stability index represents the angular excursion of the subject's center of gravity and is indicative of a high degree of movement during a test (i.e.poor balance).(study group 3 and 4)

    Measured: Three assessments will be performed: preoperatively (visit 1), 6 weeks postoperatively (visit 2) and 1 year postoperative (visit 3).

  5. Dynamic stability (Study 1)

    Instrumented gait analysis on an overground walkway to compute step width for each step from a pressure plate built into the treadmill (study group 1 to 5)

    Measured: single point measurement at Visit A (week 0)

  6. Change in dynamic stability (Study 2)

    Instrumented gait analysis on an overground walkway to compute step width for each step from a pressure plate built into the treadmill (study group 3 and 4)

    Measured: Three assessments will be performed: preoperatively (visit 1), 6 weeks postoperatively (visit 2) and 1 year postoperative (visit 3).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2019
  2. Study start10 Dec 2018
  3. Primary completion7 Dec 2021
  4. Study completion7 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03860610
Sponsor's protocol ID
2018-02159; ch19Muendermann
Other IDs
2018
Acronym
TEPStabil
Status last verified
Mar 2022
First submitted
26 Feb 2019
Last updated
4 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Postural Stability, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle strength (Study 1) (time frame: single point measurement at Visit A (week 0)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in